Tier A

Vitamin D3 (Cholecalciferol)

Also known as: Cholecalciferol · 25-hydroxyvitamin D3 precursor

26 PMID anchor · MUSCULO · IMMUNE · ENDO · METABOLISM · Last reviewed 2026-05-31

Mechanism of action

  • VDR (vitamin D receptor) ligand
  • Calcium/phosphate homeostasis
  • Immune modulation
  • Antimicrobial peptide induction (cathelicidin)

Molecular + tissue targets

  • VDR transcription factor
  • Calcium-phosphate axis
  • Innate immunity

Dosage range

600-2000 IU/day general adult; up to 4000 IU/day UL (FNB); testing for 25(OH)D status before initiating supplementation (deficiency threshold 25(OH)D < 20 ng/mL)

Safety notes

Hypercalcemia risk at sustained > 10,000 IU/day; VITAL primary endpoint negative (cardiovascular + cancer primary prevention) — secondary endpoints + subgroups disclose honestly

Cross-market regulatory status

🇺🇸 FDA

GRAS · qualified health claim (calcium + vitamin D and osteoporosis · docket 2008Q-0317)

🇪🇺 EFSA

Authorized claims for bone, muscle, immune, calcium absorption

🇧🇷 ANVISA

RDC 243/2018 dietary supplement · IN 28/2018 Anexo V 6 alegações funcionais (formação ossos+dentes · absorção Ca/P · sistema imune · funcionamento muscular · manutenção Ca sangue · divisão celular) · Anexo III ≥ 3 µg/dia adultos ≥ 19 anos (= ≥ 120 UI/dia · 1 µg colecalciferol = 40 UI)

Authorized claims · verbatim (12)

Direct quotes from each jurisdiction's framework · never paraphrased · with framework reference and conditions of use.

🇺🇸 FDA · 1 claim

21 CFR 101.72(f) Authorized Health Claim (SSA standard · docket 2008Q-0317 final rule)

Adequate calcium and vitamin D throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis.

Conditions: Significant Scientific Agreement (SSA) standard · authorized health claim (not qualified) · Conditions per § 101.72 + § 101.54(b) "high" nutrient level: food must contain ≥ 20% DV calcium per RACC + be assimilable + phosphorus ≤ calcium by weight; when vitamin D included ≥ 20% DV vitamin D per RACC; § 101.72(f) provides two model wordings (this is one of two authorized verbatim options)

Authorized 2008

🇪🇺 EFSA · 5 claims

Commission Regulation (EU) 1228/2014 art 14 (disease risk reduction claim)

Calcium and vitamin D help to reduce the loss of bone mineral in post-menopausal women. Low bone mineral density is a risk factor for osteoporotic bone fractures.

Conditions: Two-tier: Tier 1 food product composition ≥ 400 mg calcium + 15 µg (600 IU) vitamin D per daily portion; Tier 2 consumer disclosure ≥ 1200 mg calcium + 20 µg (800 IU) vitamin D per day from all dietary sources combined; target population: women aged 50 years and older

Authorized 2014

Reg 432/2012

Vitamin D contributes to the maintenance of normal bones.

Conditions: Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a "source of vitamin D" — ≥ 15% of NRV per 100 g/100 ml/portion (NRV vitamin D = 5 µg/day · Reg 1169/2011 Annex XIII)

Authorized 2012

Reg 432/2012

Vitamin D contributes to the maintenance of normal muscle function.

Conditions: Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a "source of vitamin D" — ≥ 15% of NRV per 100 g/100 ml/portion (NRV vitamin D = 5 µg/day · Reg 1169/2011 Annex XIII)

Authorized 2012

Reg 432/2012

Vitamin D contributes to the normal function of the immune system.

Conditions: Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a "source of vitamin D" — ≥ 15% of NRV per 100 g/100 ml/portion (NRV vitamin D = 5 µg/day · Reg 1169/2011 Annex XIII)

Authorized 2012

Reg 432/2012

Vitamin D contributes to normal absorption/utilisation of calcium and phosphorus.

Conditions: Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a "source of vitamin D" — ≥ 15% of NRV per 100 g/100 ml/portion (NRV vitamin D = 5 µg/day · Reg 1169/2011 Annex XIII)

Authorized 2012

🇧🇷 ANVISA · 6 claims

IN 28/2018 Anexo V alegação funcional

A vitamina D auxilia na formação de ossos e dentes.

Conditions: IN 28/2018 Anexo V: alegação restrita aos suplementos cuja quantidade de vitamina D atenda aos valores mínimos do Anexo III (≥ 3 µg/dia adultos ≥ 19 anos = ≥ 120 UI/dia · 1 µg colecalciferol = 40 UI · 0-11 meses 1,5 µg · 1-3 anos 2,25 µg · 4-18 anos 2,25 µg · gestantes 2,25 µg · lactantes 2,25 µg)

Authorized 2018

IN 28/2018 Anexo V alegação funcional

A vitamina D auxilia na absorção de cálcio e fósforo.

Conditions: IN 28/2018 Anexo V: alegação restrita aos suplementos cuja quantidade de vitamina D atenda aos valores mínimos do Anexo III (≥ 3 µg/dia adultos ≥ 19 anos = ≥ 120 UI/dia · 1 µg colecalciferol = 40 UI)

Authorized 2018

IN 28/2018 Anexo V alegação funcional

A vitamina D auxilia no funcionamento do sistema imune.

Conditions: IN 28/2018 Anexo V: alegação restrita aos suplementos cuja quantidade de vitamina D atenda aos valores mínimos do Anexo III (≥ 3 µg/dia adultos ≥ 19 anos = ≥ 120 UI/dia · 1 µg colecalciferol = 40 UI)

Authorized 2018

IN 28/2018 Anexo V alegação funcional

A vitamina D auxilia no funcionamento muscular.

Conditions: IN 28/2018 Anexo V: alegação restrita aos suplementos cuja quantidade de vitamina D atenda aos valores mínimos do Anexo III (≥ 3 µg/dia adultos ≥ 19 anos = ≥ 120 UI/dia · 1 µg colecalciferol = 40 UI)

Authorized 2018

IN 28/2018 Anexo V alegação funcional

A vitamina D auxilia na manutenção de níveis de cálcio no sangue.

Conditions: IN 28/2018 Anexo V: alegação restrita aos suplementos cuja quantidade de vitamina D atenda aos valores mínimos do Anexo III (≥ 3 µg/dia adultos ≥ 19 anos = ≥ 120 UI/dia · 1 µg colecalciferol = 40 UI)

Authorized 2018

IN 28/2018 Anexo V alegação funcional

A vitamina D auxilia no processo de divisão celular.

Conditions: IN 28/2018 Anexo V: alegação restrita aos suplementos cuja quantidade de vitamina D atenda aos valores mínimos do Anexo III (≥ 3 µg/dia adultos ≥ 19 anos = ≥ 120 UI/dia · 1 µg colecalciferol = 40 UI)

Authorized 2018

Common use cases

  • bone health
  • skeletal mineralization
  • immune support adequacy
  • fall prevention older adults
Ask Agent Axor